We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+5.58%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.01B
AUM Growth
-$40.3M
Cap. Flow
-$81.7M
Cap. Flow %
-8.12%
Top 10 Hldgs %
53.94%
Holding
5,392
New
831
Increased
1,118
Reduced
1,635
Closed
1,628

Sector Composition

Rank Sector Weight
1 Financials 3.27%
2 Industrials 2.61%
3 Consumer Discretionary 2.36%
4 Materials 2.25%
5 Technology 2.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACNB icon
3001
ACNB Corp
ACNB
$655M
$2K ﹤0.01%
61
-190
-76% -$5K
ACTG icon
3002
Acacia Research
ACTG
$470M
$2K ﹤0.01%
300
-3,973
-93% -$22.9K
ZNB
3003
Zeta Network Group
ZNB
$2.4M
0
AIRT icon
3004
Air T
AIRT
$86.1M
$2K ﹤0.01%
176
-258
-59% -$3.6K
AKO.A icon
3005
Embotelladora Andina Series A
AKO.A
$3.78B
$2K ﹤0.01%
88
-212
-71% -$4.36K
ALRM icon
3006
Alarm.com
ALRM
$2.85B
$2K ﹤0.01%
70
-619
-90% -$17.3K
AOD
3007
abrdn Total Dynamic Dividend Fund
AOD
$1.12B
$2K ﹤0.01%
+230
New +$1.75K
APLE icon
3008
Apple Hospitality REIT
APLE
$3.82B
$2K ﹤0.01%
132
-168
-56% -$3.26K
ARKW icon
3009
ARK Web x.0 ETF
ARKW
$1.75B
$2K ﹤0.01%
+92
New +$2.23K
ARLP icon
3010
Alliance Resource Partners
ARLP
$3.17B
$2K ﹤0.01%
90
-268
-75% -$5.26K
ASG
3011
Liberty All-Star Growth Fund
ASG
$341M
$2K ﹤0.01%
+496
New +$2.11K
ASM
3012
Avino Silver & Gold Mines
ASM
$1.2B
$2K ﹤0.01%
600
+200
+50% +$497
ASTE icon
3013
Astec Industries
ASTE
$1.02B
$2K ﹤0.01%
33
+32
+3,200% +$1.86K
ATLC icon
3014
Atlanticus Holdings
ATLC
$1.52B
$2K ﹤0.01%
+660
New +$1.95K
AVTX icon
3015
Avalo Therapeutics
AVTX
$983M
0
AXON
3016
Axon Enterprise
AXON
$46.4B
$2K ﹤0.01%
68
-4,051
-98% -$112K
BBP icon
3017
Virtus Biotech ETF
BBP
$105M
$2K ﹤0.01%
70
-30
-30% -$926
BCRX icon
3018
BioCryst Pharmaceuticals
BCRX
$2.4B
$2K ﹤0.01%
449
-1,968
-81% -$7.86K
BMRC icon
3019
Bank of Marin Bancorp
BMRC
$459M
$2K ﹤0.01%
80
-1,156
-94% -$28.6K
BUI icon
3020
BlackRock Utilities, Infrastructure & Power Opportunities Trust
BUI
$715M
$2K ﹤0.01%
+100
New +$1.99K
BW icon
3021
Babcock & Wilcox
BW
$1.39B
$2K ﹤0.01%
10
-96
-91% -$15.4K
CAPR icon
3022
Capricor Therapeutics
CAPR
$237M
$2K ﹤0.01%
57
-20
-26% -$752
CDTX
3023
DELISTED
Cidara Therapeutics
CDTX
$2K ﹤0.01%
11
-3
-21% -$693
CG icon
3024
Carlyle Group
CG
$17.2B
$2K ﹤0.01%
131
-677
-84% -$10.9K
CHMG icon
3025
Chemung Financial Corp
CHMG
$392M
$2K ﹤0.01%
62
-388
-86% -$11.5K

Similar funds

Tower Research Capital (TRC)'s Q3 2016 Portfolio in Review

As of Q3 2016, Tower Research Capital (TRC) held 5,392 positions worth $1.01B, down 3.8% from $1.05B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Tower Research Capital (TRC) withdrew a net $81.7M in Q3 2016, closing 1,628 positions and reducing 1,635 holdings. Its most notable exit was iShares Biotechnology ETF, an estimated $26.8M position sold in full.

By sector, the portfolio is most concentrated in Financials at 3.3% of assets, down from 6.1% a quarter earlier, followed by Industrials and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in Vanguard S&P 500 ETF worth $14.7M.

  • Tower Research Capital (TRC)'s largest Q3 2016 buy was Vanguard S&P 500 ETF: 74,203 shares worth $14.7M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2016, an estimated $303M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2016 reduction was State Street Consumer Discretionary Select Sector SPDR ETF, cutting an estimated $24.2M.
  • Tower Research Capital (TRC) fully exited iShares Biotechnology ETF in Q3 2016, selling an estimated $26.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 54% of its $1.01B portfolio in Q3 2016.
  • Tower Research Capital (TRC) opened 831 new positions and closed 1,628 in Q3 2016.
  • Tower Research Capital (TRC)'s portfolio value fell 3.8% quarter-over-quarter to $1.01B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2016, filed 8 Nov 2016.